u/Aware_Selection_7563

APLD Stock is currently trading at $39.52 right now. Okay, so Goldman Sachs just threw $300M at them for a new AI data center in North Dakota. And they got CoreWeave locked in as a tenant for 150MW. Like that's not nothing, that's actual real money coming in.

But also 30% of the float is shorted and the beta is 5.70 which means this thing moves like a caffeinated toddler. dropped from $43 to $36 in one day last week because treasury yields did something. one day.

Basically, when anything good happens the shorts panic and it flies. when the market has a bad day this thing gets absolutely cooked.

The optimists are saying $55 price target, $23B in contracted revenues blah blah. The pessimists are pointing at $2.83B in debt and negative cash flow and saying the valuation only makes sense if you squint really hard and pretend it's 2028

The earnings on July 29 and i genuinely have no idea if this thing goes to $60 or $20 after that. Next earnings are July 29. That report is going to be wild either way.

Applied Digital Corporation has spent much of 2026 doing what it does best: making investors uncomfortable sitting still.

The stock is currently trading at $39.52, up more than 40% year-to-date, and up roughly 483% over the past twelve months.

If you've been searching why APLD stock is going up, or conversely, why it keeps dropping without warning, the answer lies in a mix of real business catalysts, macro AI tailwinds, and the kind of volatility that comes with a beta of 5.70.

https://preview.redd.it/qhuj0zn8v22h1.png?width=1787&format=png&auto=webp&s=c12f94083ab6674740a192271058bb3c56226b9f

So I've spent a stupid amount of time digging through SEC Edgar filings and backtesting insider transactions against actual price outcomes.

Let me share what the data says specifically about Intel ($INTC), because the numbers are genuinely interesting, not in a Reddit hype way, but in a "this is statistically weird and probably worth understanding" way.

The Setup

Between 2019 and early 2026, Intel executives and directors made 58 open-market purchases of their own stock, meaning they used personal cash, not options, not grants. Just bought shares like anyone else would.

When that happens, what does the stock do?

• Day 1 median return: +0.63%
• Day 3 median return: +1.53%
• Day 5 median return: +2.59%
• Day 20 median return: +2.16%

That last number is what I find most interesting. The drift doesn't continue forever, it actually fades slightly after Day 5. So, whatever signal insider buying creates, it plays out fast. You're looking at a roughly 5-day edge, then the market absorbs it and moves on.

The 5-day win rate across all 58 cases: 69%. For a large-cap stock, that's a statistically notable number. It's not 90%. It's not a magic formula. But 69% is meaningfully above coin-flip territory.

What Happens When Insiders Buy Into a Falling Stock

This is where it gets more interesting.

Of those 58 buys, 27 happened when Intel had already dropped more than 2% in the 5 days before the filing. The executive bought into weakness, not strength.

In those specific cases, the 5-day median return expanded to +3.27%. an extra 0.68% over the baseline.

The interpretation isn't complicated: when someone with deep knowledge of the business buys the dip with their own money, it's a stronger signal than buying into a flat or rising tape. The "floor" behavior is more pronounced.

Real Examples From the Data (Both Wins and Losses)

January 26, 2026: Intel's CFO David Zinsner bought ~$250k worth of shares at $42.50. The stock returned +12.1% over the next 5 days. Huge. Clean signal.

August 5, 2024: CEO Pat Gelsinger made two separate purchases on the same day ($152k and $99k). Cluster buys from a CEO tend to carry more conviction than a single order. 5-day return: +4.89%.

May 1, 2024 and April 29, 2024: Also Gelsinger buys. Stock drifted slightly negative (~-0.8%). These are the failures that make the 69% realistic. Any backtest that doesn't include the losses is selling you something.

Why Most People Ignore This Data

The main reason is that it's annoying to collect. SEC EDGAR filings aren't cleanly structured, the dates don't always align cleanly with trading days, and you have to manually filter out option exercises, gift transfers, and 10b5-1 plan purchases from genuine open-market buys. The noise is high.

When you do filter it properly and align it with actual OHLC data, though, you get a surprisingly coherent picture, at least for a stock like Intel, where insider transactions are frequent enough to build a meaningful sample.

This is one ticker, and 58 data points isn't a massive sample. I'm not saying this works universally or that it's some edge case Wall Street is sleeping on. Smart money already watches this, the question is whether retail traders have the same quality of signal or are always reacting a few days late.

Curious if anyone else has done similar backtesting on insider filings for other large-caps, or if there's a sector where this signal tends to be stronger or weaker. Energy and semiconductors seem like obvious candidates to me, but I haven't gone deep on them yet.

And honestly, if a system existed that tracked this automatically, surfaced the weak vs. strong setups, and delivered the historical context upfront instead of requiring you to dig for it yourself, would that be something you'd actually want to use? Seems like a gap that's always existed but has never been filled well for regular investors.

Most coverage of EchoStar Corporation right now is written in one of two modes. Either it is breathlessly bullish about the FCC approvals and the $40 billion spectrum deals, or it is flatly bearish because of the $29.24 billion debt load and the negative net margin. Neither framing is particularly useful to someone trying to make an actual investment decision.

EchoStar Corporation has been one of the more interesting stories in telecom over the past three years. From a 52-week low of $14.90 to a recent high of $139.54. Read the full Analysis here.

EchoStar (SATS) went from $14.90 to $139.54 in twelve months. The FCC approved a $40 billion spectrum deal. The stock is near all-time highs. So why did short interest just grow by 24 percent in a single month?

That is the thing I cannot get out of my head.

Short interest went from 33 million to 41 million shares between March and April. The FCC approval came through in May. The shorts grew their position before the catalyst hit and clearly did not cover in a panic afterward. That is not a group of retail traders making an emotional bet. That is a calculated position from people who have studied the balance sheet closely.

And the balance sheet gives you a reason. $29.24 billion in debt. Negative operating cash flow of $67.84 million. Current ratio of 0.30. The Altman Z-Score, a model that flags bankruptcy risk, sits at negative 0.97. Days to cover on the short position is 6.7, meaning it takes almost a week of average volume to clear all short positions. That is not an extreme squeeze setup but it is enough to make the stock volatile in either direction on any meaningful news.

The technicals are bullish on the surface. The stock is above the 50-day moving average at $120.72 and the 200-day at $92.56. MACD is positive. RSI is 64.4, which is elevated. The stock also gained 12.83% in 15 days and is pressing against the upper Bollinger Band at $137.32. That is not a momentum setup where you chase. That is a setup where you wait.

The spectrum deal is real. Over $40 billion in deal value between the SpaceX and AT&T transactions is not made-up news. The question is timing and capital allocation. When do the deals close, and where do the proceeds go? If $15 to $20 billion in net proceeds goes to debt repayment, the financial picture changes and the bears cover. If the closing drags or the money gets absorbed by operational needs, the bears look smart.

Revenue is $14.80 billion trailing twelve months but declining at 5.2% year over year. Gross margin is 27%. EBITDA margin is 10.7%. The operating business works. The debt sitting on top of it is what makes this complicated.

Five analysts cover SATS. Consensus is Buy. Average price target is $129.60. That is below where the stock is trading today at $137.23. Even the optimists on Wall Street think you are paying a premium right now.

Next earnings is July 30, 2026. That is the moment of truth. Either the balance sheet shows improvement from the deal proceeds or it doesn't. Everything between now and then is news-driven noise.

The setup I would actually want, a pullback to $127 where the 20-day moving average sits, a confirmation that the deal is on track to close, and then a look at July earnings. That gives you a defined risk and a clear thesis trigger. Jumping in at $137 when the stock is extended against resistance and short interest is still this elevated is a different game.

Not a financial advisor.

Interesting valuation setup for $SATS Stock here.

Current Price: $137.23
Tickzen Fair Value Estimate: $127.26 (-7.3%)

What stands out:

• Analyst target sits near current levels at $129
• EV/Revenue model suggests upside to $177
• P/B valuation implies downside toward $79

The stock doesn’t look massively overvalued or deeply undervalued right now. Instead, the valuation models are sending mixed signals depending on which metric you prioritize.

This is why relying on a single ratio can be misleading during stock research.

https://preview.redd.it/x1byg00v8v1h1.png?width=1765&format=png&auto=webp&s=e28b5d85ec33c04e335de998b72ba8f9270a3a71

https://preview.redd.it/jr2wtm9muu1h1.png?width=2129&format=png&auto=webp&s=e7ce237b6b77a6101edfaaf8063b8023d4858d30

$NBIS Stock -

Wall Street says this stock could go higher.
Valuation models say it may already be overpriced.

Current Price: $219.94
Tickzen Fair Value Estimate: $147.12

What’s interesting:
• Analyst consensus target → $248
• EV/Revenue implied value → $58.85
• Estimated downside from fair value → -33.1%

This is exactly why smart investors don’t rely on a single metric.

One side sees growth.
The other sees stretched valuation.

Would you still buy at these levels?

How a 85-person semiconductor company is quietly becoming a critical piece of U.S. defense infrastructure.

There’s a pattern with small-cap semiconductor stocks. They operate in obscurity for years, serve genuinely important markets, and then one announcement flips the narrative entirely. Everspin Technologies (NASDAQ: MRAM) is going through exactly that right now and while the 172% stock move in 15 days grabbed the headlines, the actual business development underneath is what deserves serious attention.

DCF model + analyst consensus + sector multiples. Takes me about a minute. You get the fair value, the implied upside or downside from today's price, and the confidence level.

Not financial advice, just the number. Drop your ticker below.

I kept seeing MRAM mentioned after it went from 13.81 to 37.57 in 15 trading days, and decided to actually sit down and look at the fundamentals rather than just the chart. Here is what I found.

The move was not random or purely retail-driven. Everspin Technologies announced a 40 million dollar subcontract with a U.S. defense prime contractor on April 30 to supply Toggle MRAM technology for Defense Industrial Base programs. The contract runs 2.5 years. Their total trailing twelve-month revenue is 55.2 million dollars. That one contract alone is worth more than 70 percent of annual revenue locked into backlog.

Alongside that, they separately announced a 10-year manufacturing agreement with Microchip Technology to expand U.S.-based MRAM production capacity. The defense procurement trend heavily favors domestically sourced components right now, and that deal makes Everspin a more eligible supplier for future programs before those programs even go to bid.

Q1 2026 results backed the narrative too. Revenue was 14.87 million versus 13.14 million a year earlier, the net loss narrowed to just 296,000 dollars, and gross margin hit 52.7 percent. Q2 guidance calls for 15.5 to 16.5 million in revenue.

Now, the part that keeps me from piling in at current levels.

The stock has a trailing P/E of 3,757 times because earnings are essentially zero on a GAAP basis. The forward P/E is 80.8 times. The two analysts who cover it have a mean price target of 18.00 dollars, which implies 52 percent downside from 37.57. Fair value models come in around 17 dollars.

The RSI is at 73.9, which is overbought, and the recent rally has not been backed by consistently expanding volume. Volume dropped from 15.7 million shares on May 13 to 4.4 million by May 15 as the price held up.

Insider activity also caught my attention. Over the last three months, there were nine open-market sales averaging 27.91 USD per share and zero open-market purchases. That does not sink the thesis but it is worth knowing.

The technology itself is genuinely interesting. Everspin is the only company commercially shipping MRAM at scale. Toggle MRAM is radiation-tolerant, non-volatile, and operates across a wide temperature range. For defense applications, those are not nice-to-have features. They are requirements that eliminate most alternatives. Once a defense program designs this into a platform, the switching cost to change memory suppliers is enormous.

The balance sheet is fine. 44.45 million in cash, 3.34 million in debt, current ratio of 4.84. Altman Z-Score of 9.54 puts it in safe territory. Operating cash flow over the trailing twelve months was 9.96 million dollars.

My opinion: The valuation at current prices has already priced in a lot of the good news and then some. The technically cleaner entry would be a pullback toward the 20-day moving average around $27.46, or a confirmed breakout above 45.54 on heavy volume.

Everspin Technologies has had one of the more dramatic moves in the semiconductor space this month. The stock went from $13.81 on April 27 to $37.57 as of May 17. The catalyst was real: a 40 million dollar defense subcontract, a 10-year manufacturing deal with Microchip Technology, and a Q1 earnings report showing revenue growth and a narrowing net loss.

I want to be clear that the underlying business development is genuinely significant. That $40 million contract represents more than 70 percent of Everspin's annual revenue in committed backlog across 30 months. The company is the only commercial producer of MRAM at scale, the technology has deep moat characteristics in defense and aerospace applications, and the balance sheet is solid with $44.45 million in cash against $3.34 million in debt.

But here is where I think a lot of investors are getting ahead of themselves.

The two analysts who cover this stock have a mean price target of 18.00 USD. The stock trades at $37.57. That is a 52 percent gap between where the smart money thinks fair value is and where retail investors are currently paying. Fair value models using a blended EV/Revenue approach come out around 17 dollars. The forward P/E is 80.8 times, which is speculative territory for a company that posted a negative 1.06 percent net margin over the trailing twelve months.

The RSI is at 73.9, firmly overbought. Volume has been fading as prices hold near the highs, which is not the pattern you want to see in a sustainable breakout. Insider activity has leaned toward selling: nine open-market sales in the last three months, zero open-market purchases. Short interest has also ticked up from 753,000 to 903,000 shares between March and April 2026.

None of that means the stock is going to collapse. Stocks with genuine catalysts can stay overbought for a long time. But it does mean you are taking on considerably more risk buying at $37.57 than someone who got in at 1$3.81 three weeks ago, and the margin of safety that most value-oriented investors want simply is not there at current prices.

The 30-day historical volatility is 215.5%. This stock can move 10% in a session without warning. Position sizing matters a lot here.

The Q2 2026 earnings report is going to be the real test. That is when the defense contract revenue starts showing up and you will see whether the income statement is actually inflecting. Revenue guidance of 15.5 to 16.5 million for Q2 is encouraging. The question is whether operating margin starts moving with it.

If you believe the 40 million dollar defense deal is the first of several contracts and that Everspin becomes a durable supplier to U.S. defense programs over the next five years, the current price might look reasonable in hindsight. If execution stumbles, $37.57 will be painful.

The more patient entry is a pullback toward $27.46. That is the 20-day moving average and a much better risk-reward than chasing here.

$MRAM is up 172 percent in 15 trading days and most of the discussion I have seen treats it like a momentum trade. I want to make the case that the underlying catalyst here is more substantial than the typical small-cap pump, and also be honest about where the risk is.

Everspin Technologies signed a 40 million dollar subcontract with a U.S. defense prime contractor on April 30. They supply Toggle MRAM, which is a type of memory chip that does not need power to retain data, tolerates radiation, and works in extreme temperature conditions. Those characteristics sound boring until you realize they are exactly what you need in a missile system, military satellite, or classified avionics platform.

Here is the part that makes this interesting from a business standpoint. The company's total annual revenue is 55.2 million dollars. One contract is worth 40 million dollars across 30 months. That is not a random customer. That is a strategic backlog that changes the revenue visibility of this business overnight.

They also announced a 10-year manufacturing deal with Microchip Technology the same week. Defense procurement increasingly requires domestically manufactured components. That deal makes Everspin eligible for contracts they probably could not win before from a sourcing compliance standpoint.

Q1 2026 revenue grew 11.8 percent year over year. Net loss was only 296,000 dollars, which for a company this early in its growth cycle is nearly breakeven. Gross margin is 52.7 percent.

Now let me be honest about the stock itself because I know this audience appreciates actual information over just cheerleading.

The RSI is at 73.9. Overbought. The stock is 36.8 percent above its 20-day moving average. Volume has been declining as prices hold near the highs, which is not confidence-inspiring. Analyst price targets are at 18.00 dollars, and the stock trades at 37.57. Insiders have been selling into the rally with nine open-market sales and zero purchases in the last three months.

The 30-day historical volatility is 215.5 percent. This is a stock that can move violently in both directions without much notice.

The balance sheet is actually fine though. 44.45 million in cash, 3.34 million in debt. The Altman Z-Score is 9.54 which means the bankruptcy risk the shorts usually point to is basically nonexistent.

The setup I am watching: if MRAM pulls back to the 27.46 dollar level which is the 20-day moving average, that is a much more interesting entry than the current 37.57. If it breaks above 45.54 on real volume, that is the next leg confirmation.

Everspin is the only company commercially shipping MRAM at scale. That does not mean the stock at any price is a good trade. It does mean the company has something that cannot be easily replicated, which is more than most small-cap plays can say.

What is your take on the defense angle? Does the contract change the long-term thesis for you, or is this still a momentum story?

Everspin Technologies (NASDAQ: MRAM) has had one of the more dramatic runs you’ll see in the semiconductor space this year. Between April 27 and May 15, 2026, the stock went from $13.81 to $37.57 — a 172% move in 15 trading sessions. That kind of run makes investors do one of two things: chase it or panic-sell. Neither is a great default reaction.

So let’s slow down and actually look at what the numbers say because the MRAM stock story in 2026 is more nuanced than the headline return suggests.

Delta Air Lines stock trades 37 percent below its blended fair value estimate. Here is the full breakdown of the DAL DCF valuation, risk factors, and what the options market is telling us right now

A deep dive into DAL stock fundamentals, valuation, and why Berkshire Hathaway just made a 2.6 billion dollar bet on Delta Air Lines.

https://preview.redd.it/7rof2ucnnh1h1.png?width=1804&format=png&auto=webp&s=4bdb7c52d25465e8cbd4bdcf05dac354bb280a2d

I ran a fair value estimate on $DAL stock today, and the numbers are interesting.

Current price is around $70 while the blended fair value estimate sits near $97, which shows roughly 38 percent upside from current levels.

Also, it is interesting that multiple valuation methods are pointing in the same direction:

DCF model: $102
Analyst consensus: $80
EV revenue Multiple: $121

The analyst target is more conservative, but the overall weighted estimate still suggests the stock may be trading below intrinsic value right now.

The confidence level came out high because the estimate is based on multiple sources instead of relying on a single model.